Table 2.

Detailed demographic, clinical, and transplant‐associated patient findings

No.	Sex	Reason for HSCT	Donor	HLA mismatch	Cause of ESRD	Age (y)		IS after RT	IS‐free (y)
						At RT	Donor
1	M	Wiskott‐Aldrich Syndrome	Mother	Two mismatches	Mesangial proliferative GN	18	42	Glucocorticoids, CyA	24
2	F	ALL	Brother	HLA‐identical	HUS	28	25	None, later AZA and Glucocorticoids	0
3	F	Aplastic anemia	Father	Three mismatches	Radiation nephritis	14	NK	Glucocorticoids, CyA	21
4	F	CML	Sister	Two mismatches	BMT‐NP	37	35	None	19
5	F	AML	Brother	HLA‐identical	HUS	40	NK	Glucocorticoids and AZA	NK
6	M	AML	Sister	HLA‐identical	BMT‐NP	39	33	None	10
7	M	Morbus Hodgkin	Brother	HLA‐identical	BMT‐NP	48	51	None	4
8	F	AML	Unrelated	HLA‐identical	BMT‐NP	29	NK	None	9
9	F	CML	Sister	HLA‐identical	Diabetes type 1	37	NK	None	17
10	M	CML	Sister	HLA‐identical	Unknown	64	56	None	11
11	M	Lymphoma	Sibling	HLA‐identical	HUS/TTP	59	67	MMF, Glucocorticoids	5
12	F	ALL	Mother	One mismatch	BMT‐NP	30	57	MMF, Glucocorticoids	5
13	M	AML	Father	Two mismatches	CNI‐associated	21	45	Tac, MMF, Glucocorticoids	9
14	M	AML	Sister	HLA‐identical	TTP	28	26	Tac, MMF	3
15	F	Comb. immune‐deficiency syndrome	Mother	Three mismatches	Loss of first renal allograft due to infection	22	61	CyA, Glucocorticoids	6
16	M	Idiopathic aplastic anemia	Sister	HLA‐identical	Chronic nephangiosclerosis	41	52	Glucocorticoids	9
17	F	AML	Unrelated	HLA‐identical	Complication of aGvHD treatment	17	46	Tac, Glucocorticoids	9
18	M	Polymorphic rhabdomyosarkoma	Father	Two mismatches	BMT‐NP	21	43	Glucocorticoids	3
19	M	ALL	Father	Three mismatches	BMT‐NP	25	46	Glucocorticoids	1
20	M	B‐cell non‐Hodgkin lymphoma	Sister	HLA‐identical	Acute and chronic rejection of 1. transplant kidney	30	22	Glucocorticoids	13
21	M	Aplastic anemia	Sister	HLA‐identical	CNI toxicity	54	63	Single Dose Glucocorticoid	1,5
22	F	Sickle cell disease	Mother	Three mismatches	Focal segmental glomerulosclerosis due to SCD	28	56	Glucocorticoid, MMF, Tacrolimus	0,2

By some authors the cause of ESRD was described as bone marrow transplant nephropathy (BMT‐NP). In the literature BMT‐NP is defined as chronic renal disease presenting within 100 days after BMT. It includes chemo‐irradiation–associated nephropathies caused by the conditioning therapies in the absences of other nephrotoxins.14, 40